A MODERN VIEW ON ALLERGIC RHINITIS: PATHOGENESIS, DIAGNOSIS, AND THERAPY

DOI: https://doi.org/10.29296/25419218-2019-04-01
Issue: 
4
Year: 
2019

Z.D. Khadzhieva, D.I. Pozdnyakov, A.E. Rybalko, L.P. Lezhneva, N.S. Aleinikova Pyatigorsk Medical Pharmaceutical Institute, Branch, Volgograd State Medical University, 11, Kalinin Prospect, Pyatigorsk 357532, Russian Federation

The paper reviews the etiology, features of pathophysiology, diagnosis, and pharmacotherapy of allergic rhinitis. Allergic rhinitis is a common disease. The classic symptoms of the disease are nasal congestion, nasal itching, rhinorrhea, and sneezing. The negative sequelae of allergic rhinitis include sleep disorders, fatigue, decreased concentration, and restricted daily activities and are associated with chronic nasal mucosal inflammation, which leads to nasal congestion and adversely affects a patient’s general condition; in particular ventilation dysfunction of the nasal passages can provoke insomnia. Significant clinical symptom variability, risk factors, and sequelae of allergic rhinitis necessitate an accurate diagnosis of allergic rhinitis and also require the elaboration of an optimal treatment strategy for the disease. The criteria for the most accurate diagnosis of allergic rhinitis are history data, physical examination, and allergy skin testing. The use of anti-allergic drugs, such as second- and third-generation oral antihistamines, as well as intranasal corticosteroids, which are basic therapy for allergic rhinitis, plays a decisive role in the rational therapy of allergic rhinitis.

Keywords: 
allergy
rhinitis
allergic rhinitis
antihistamines

References: 
  1. Kakumanu S., Glass C., Craig T. Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. Send to Am. J. Respir. Med., 2002; 1 (3): 195–200.
  2. Sinha B., Vibha, Singla R, Chowdhury R. Allergic Rhinitis: A neglected disease - A community based assessment among adults in Delhi. J. Postgrad. Med., 2015; 61 (3):169–75. https://doi.org/10.4103 / 0022-3859.159418.
  3. Chernjak B.A., Vorzheva I.I. Komorbidnye zabolevanija pri allergicheskom rinite. Astma i allergija, 2017; 1. 3–7 [Chernyak B.A., Vorzheva I.I. Comorbid diseases in allergic rhinitis. Astma i allergiya. 2017. 1. 3–7 (in Russian)].
  4. Hadzhieva Z.D., Alejnikova N.S., Lezhneva L.P., Rybalko A.E. Perspektivy primenenija preparatov rastitel'nogo proishozhdenija v terapii zabolevanij verhnih dyhatel'nyh putej. Uspehi sovremennoj nauki i obrazovanija, 2016; 11 (4): 154–6. [Hadzhieva Z.D., Alejnikova N.S., Lezhneva L. P., Rybalko A. E. Prospects for the use of herbal drugs in the treatment of diseases of the upper respiratory tract. Uspekhi sovremennoy nauki i obrazovaniya, 2016; 11 (4): 154–6 (in Russian)].
  5. Tran N.P., Vickery J., Blaiss M.S. Management of rhinitis: allergic and non-allergic. Allergy Asthma Immunol Res., 2011; 3 (3): 148–56. https://doi.org/10.4168 / AAIR.2011.3.3.148.
  6. Poddighe D., Licari A., Caimmi S., Marseglia G.L. Sublingual immunotherapy for pediatric allergic rhinitis: The clinical evidence. World J. Clin. Pediatr., 2016; 5 (1): 47–56. https://doi.org/10.5409/wjcp.v5.i1.47
  7. Hadzhieva Z.D., Alejnikova N.S. Izuchenie klassifikatsionnyh priznakov zabolevanij verhnih dyhatel'nyh putej. Uspehi sovremennoj nauki i obrazovanija, 2017; 3 (6): 199–203. [Hadzhieva Z.D., Alejnikova N.S. The study of the classification signs of diseases of the upper respiratory tract. Uspekhi sovremennoy nauki i obrazovaniya, 2017; 3 (6): 199–203 (in Russian)].
  8. Zheng M., Wang X., Ge S., Gu Y., Ding X., Zhang Y., Zhang L. Allergic and Non-Allergic Rhinitis Are Common in Obstructive Sleep Apnea but Not Associated With Disease Severity. Journal of Slinical Sleep Medicine: official publication of the American Academy of Sleep Medicine, 2017; 13 (8): 959–66. https://doi.org/10.5664/jcsm.6694
  9. Lee Y.S., Kim S.H., You J.H. et al. Attention deficit hyperactivity disorder like behavioral problems and parenting stress in pediatric allergic rhinitis. Psychiatry Investig., 2014; 11 (3): 266–271. https://doi.org/10.4306 / pi.2014.11.3.266.
  10. Young T., Finn L., Kim H. Nasal obstruction as a risk factor for sleep disordered breathing. J. Allergy. Clin. Immunol., 1997; 99 (2): 757–62.
  11. Chelenkova I.N., Uteshev D.B., Bunjatjan N.D. Ostrye i hronicheskie vospalitel'nye zabolevanija verhnih dyhatel'nyh putej. Russkij meditsinskij zhurnal, 2010; 80 (30): 1878–82. [Chelenkova I.N., Uteshev D.B., Bunyatyan N.D. Acute and chronic inflammatory diseases of the upper respiratory tract. Russkiy medicinskiy zhurnal, 2010; 80 (30): 1878–82 (in Russian)].
  12. Small P., Keith P.K., Kim H. Allergic rhinitis. Allergy, Asthma and Clinical Immunology. 2018; 14. (Suppl 2): 51. https://doi.org/10.1186 / s13223-018-0280-7
  13. Dykewicz M.S., Hamilos D.L. J Rhinitis i sinusitis. Allergy Clin Immunol. 2010, 125 (2 Suppl 2): 103–15. https://doi.org/10.1016 / j.jaci.2009.12.989.
  14. Campo P., Rondon C., Gould H.J., Barrionuevo E., Gevaert P., Blanca M. Local IgE in non-allergic rhinitis. Clin. Exp. Allergy., 2015; 45 (5): 872–81. https://doi.org/10.1111/cea.12476
  15. Hadzhieva Z.D., Alejnikova N.S. Izuchenie farmatsevticheskogo rynka kombinirovannyh lekarstvennyh preparatov protivovospalitel'nogo dejstvija. Uspehi sovremennoj nauki i obrazovanija, 2017; 9 (3): 152–6. [Hadzhieva Z.D., Alejnikova N.S. Study of the pharmaceutical market of combined anti-inflammatory drugs. Uspekhi sovremennoy nauki i obrazovaniya. 2017; 9 (3): 152–6 (in Russian)].
  16. Varshney, Jitendra and Himanshu Varshney. Allergic Rhinitis: an Overview. Indian journal of otolaryngology and head and neck surgery, 2015; 67 (2): 143–9. https://doi.org/10.1007 / S12070-015-0828-5
  17. Hoyte F.C., Nelson H.S. Recent advances in allergic rhinitis. 2018; 7: 1000–1333. https://doi.org/10.12688/f1000research.15367.1
  18. Gosudarstvennyj reestr lekarstvennyh sredstv. [Elektronnyj resurs]. Rezhim dostupa: http://grls.rosminzdrav.ru/grls.aspx. [State Register of medicinal products. [Electronic resource]. Access mode: http://www.grls.rosminzdrav.ru/Default.aspx (in Russian)]
  19. Chuchalin A.G., Avdeev S.N., Arhipov V.V., Babak S.L. i dr. Ratsional'naja farmakoterapija zabolevanij organov dyhanija. M.: Litterra, 2004; 874. [Chuchalin A.G., Avdeev S.N., Arhipov V.V., Babak S.L. et al. Rational pharmacotherapy of respiratory diseases. Moscow: Litterra, 2004; 874 (in Russian)].
  20. Spada F., Barnes T.M., Greive K.A. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids. The Australasian journal of dermatology, 2017; 59 (3), 168–74. https://doi.org/10.1111 / ajd.12762.
  21. Haarman M.G., van Hunsel F., de Vries T.W. Adverse drug reactions of montelukast in children and adults. Pharmacology research & perspectives, 2017; 5 (5). https://doi.org/10.1002 / prp2.341
  22. Moote W., Kim H., Ellis A.K. Allergen-specific immunotherapy. Allergy, Asthma and Clinical Immunology, 2018. 14 (Suppl 2), 53. https://doi.org/10.1186/s13223-018-0282-5
  23. Hadzhieva Z.D., Alejnikova N.S. Analiz nomenklatury gotovyh lekarstvennyh sredstv dlja naruzhnogo primenenija. Uspehi sovremennoj nauki i obrazovanija, 2017; 9 (4): 151–5. [Hadzhieva Z.D., Alejnikova N.S. Analysis of the range of finished medicinal products for external use. Uspekhi sovremennoy nauki i obrazovaniya, 2017; 9 (4): 151–5